One more study with RehaCom proves the effectiveness. This time in patients with Secondary Progressive Multiple Sclerosis.
RehaCom Home Training application starts in USA
NYU Langone Health is the first facility in the USA to use the RehaCom Home Training of HASOMED GmbH. The project at the medical education and research institution is led by Prof. Leigh Elkins Charvet.
RehaCom is available in Japan now
With RehaCom, HASOMED GmbH has been on the market for more than 20 years. Kissei Pharmaceutical widens the possibilities of cognitive rehabilitation of patients in Japan now.
Medica 2019: Innovative HASOMED medical devices at the World Forum of Medicine
The UN forecasts a world population of more than 9.7 billion people by 2050. A challenge for medical care and a task that physicians and manufacturers of medical technology can master together. Medica 2019, World Forum of Medicine, creates the link between medicine and medical technology, present an…
RehaCom and RehaIngest presented in Greece
Two HASOMED GmbH therapy systems made a strong appearance in Greece at the end of October 2019: At a conference for neuropsychologists, the internationally renowned neuropsychologist Dr. Lambros Messinis presented his current study on the use and benefits of RehaCom. The study focused on patients wi…
Strong performance for RehaIngest and RehaCom in Lithuania
Medlinkas UAB, partner of HASOMED in Lithuania, presents RehaCom and RehaIngest on 25 and 26 October 2019. Both systems are suitable for treating patients suffering from the consequences of a stroke. With RehaIngest a visualized swallow measurement is possible, RehaCom supports brain performance tra…
New version: RehaCom 6.9 released
RehaCom is now available in version 6.9. With the software update, HASOMED has completely revised the training modules "Reaction Behaviour" (REVE) and "Logical Reasoning" (LODE) and added cognitive training topics.
RehaCom 6.9 supports therapists in treating the consequences of s…